NASDAQ:ZIVO

ZIVO Bioscience 11/13/2026 Earnings Results & Report

ZIVO Bioscience logo
$5.50 -0.26 (-4.51%)
As of 03:27 PM Eastern

ZIVO Bioscience was expected to report earnings on November 13, 2026. Analysts expected earnings of -$0.26 per share on revenue of $351 thousand. Confirmed results have not been posted yet. This page will update with the reported figures, conference call transcript, and earnings documents as they become available.

Earnings Announcement Details

Announcement Date

ZIVO Bioscience EPS Results

Actual EPS
N/A
Consensus EPS
-$0.26
Beat/Miss
N/A
One Year Ago EPS
N/A

ZIVO Bioscience Revenue Results

Actual Revenue
N/A
Expected Revenue
$351 thousand
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

ZIVO Bioscience Earnings FAQ

ZIVO Bioscience's next earnings date is estimated for Wednesday, December 2, 2026. MarketBeat tracks confirmed and estimated earnings dates for ZIVO Bioscience on the company's earnings history page.

ZIVO Bioscience Earnings Headlines

Zivo Bioscience Inc. Wt
Your father's savings lost half their value after 1971.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel
ZIVO Bioscience Provides Special Letter to Shareholders
See More ZIVO Bioscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ZIVO Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ZIVO Bioscience and other key companies, straight to your email.

About ZIVO Bioscience

ZIVO Bioscience (NASDAQ:ZIVO) is a biotechnology company that develops products based on proprietary algal strains, biomass and bioactive compounds. Its research programs target applications in animal health and human health and wellness.

In animal health, the company has focused on developing an algae-derived feed ingredient for poultry, including research into supporting poultry health. ZIVO has also investigated potential human-health applications for compounds derived from its algae. These are development programs, rather than a broad portfolio of established commercial products.

The company was formerly known as Z Trim Holdings, Inc. and adopted the ZIVO Bioscience name as it shifted its focus toward biotechnology and algae-based research. ZIVO is based in the United States.

View ZIVO Bioscience Profile